Table 1. Clinical Characteristics of the... | American Society of Hematology

Table 1.

Clinical Characteristics of the Patients Studied

Characteristics	No.	%	Mean ± 1 SD
Total	145	100
Gender
Male	85	59
Female	60	41
Age (median, 35 yr; range, 16-75 yr)
15-19	17	12
20-29	43	29
30-39	27	19
40-49	27	19
50-59	10	7
60-69	17	11
70-75	4	3
Histology
Lymphocyte predominance	2	1
Nodular sclerosis	68	46
Lymphocyte depleted nodular sclerosis	20	14
Mixed cellularity	42	30
Lymphocyte depletion	13	9
Stage
II B	45	31
III₂ A	22	15
III B	39	27
IV A	11	8
IV B	28	19
Mediastinal bulk	47	32
Spleen involvement	29	20
Extranodal involvement
Bone marrow	22	15
Lung	9	6
Liver	6	4
Other visceral organs	3	2
Hb <100 g/L	16	11	119 ± 20
ESR >40 mm 1st hour	95	66	61.6 ± 37.6
Serum LDH >450 U/L	33	23	400 ± 225
Serum albumin <30 g/dL	26	18	3.64 ± 0.59
SNLG prognostic index >0.5	52	36	0.39 ± 0.2
IDHD probability of surviving at 5 yr			0.71 ± 0.18

Characteristics	No.	%	Mean ± 1 SD
Total	145	100
Gender
Male	85	59
Female	60	41
Age (median, 35 yr; range, 16-75 yr)
15-19	17	12
20-29	43	29
30-39	27	19
40-49	27	19
50-59	10	7
60-69	17	11
70-75	4	3
Histology
Lymphocyte predominance	2	1
Nodular sclerosis	68	46
Lymphocyte depleted nodular sclerosis	20	14
Mixed cellularity	42	30
Lymphocyte depletion	13	9
Stage
II B	45	31
III₂ A	22	15
III B	39	27
IV A	11	8
IV B	28	19
Mediastinal bulk	47	32
Spleen involvement	29	20
Extranodal involvement
Bone marrow	22	15
Lung	9	6
Liver	6	4
Other visceral organs	3	2
Hb <100 g/L	16	11	119 ± 20
ESR >40 mm 1st hour	95	66	61.6 ± 37.6
Serum LDH >450 U/L	33	23	400 ± 225
Serum albumin <30 g/dL	26	18	3.64 ± 0.59
SNLG prognostic index >0.5	52	36	0.39 ± 0.2
IDHD probability of surviving at 5 yr			0.71 ± 0.18